Cargando…
LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
Background: Drug resistance of cancer cells is one of the major causes of chemotherapy failure. Recently research demonstrated that long non-coding RNA Urothelial cancer associated 1 (UCA1) could promote tumor cisplatin resistance. In this study, we aim to investigate the role of UCA1 in the cisplat...
Autores principales: | Dai, Qingqiang, Zhang, Tianqi, Pan, Jiaomeng, Li, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171500/ https://www.ncbi.nlm.nih.gov/pubmed/32328192 http://dx.doi.org/10.7150/jca.43446 |
Ejemplares similares
-
LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
por: Dai, Qingqiang, et al.
Publicado: (2020) -
Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway
por: Pan, Jiaomeng, et al.
Publicado: (2019) -
Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway
por: Li, Chengyun, et al.
Publicado: (2017) -
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
por: Yang, Dongyong, et al.
Publicado: (2021) -
Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma
por: Fu, Jiali, et al.
Publicado: (2021)